Weight-Loss Surgery Can Prolong Life. Part 3 of 3

Tags

, ,

Weight-Loss Surgery Can Prolong Life – Part 3 of 3

The estimated death rates for patients who didn’t have weight-loss surgery were about 10 percent at five years, and about 24 percent at 10 years.Recent surgical improvements should effect even better results today, one expert said. “The results of the ruminate on could be better if it were done now,” said Dr John Morton, chief of bariatric and minimally invasive surgery at Stanford University School of Medicine in Stanford, California Since more than 90 percent of weight-loss surgery now is done with minimally invasive procedures that use smaller incisions and embody fewer complications, survival should be even greater, he contends ayurveda.

Parts: 1 2 3

Advertisements

Weight-Loss Surgery Can Prolong Life. Part 2 of 3

Tags

, ,

Weight-Loss Surgery Can Prolong Life – Part 2 of 3

So “The main risk from surgery is the risk of dying from a major predicament such as bleeding or infection, which typically occurs in less than 0,3 percent of patients. Other possible complications include blood clots in the legs or lungs or the need for another operation because of a surgical problem, bleeding or infection. For the study, Arterburn and his colleagues tracked 2500 patients who had weight-loss surgery at Veterans Affairs bariatric centers from 2000 to 2011.

patients

Their middling age was 52 and their body preponderance index (BMI) was 47, which is considered extremely obese. Three-quarters of the patients had gastric bypass surgery, which alters the way the stomach and intestines handle food. Fifteen percent underwent sleeve gastrectomy, which reduces the extent of the stomach, and 10 percent had adjustable gastric banding, which reduces food intake. The researchers compared these patients with about 7500 patients of equivalent age and size who did not have a weight-loss procedure.

Over 14 years of follow-up, 263 patients who had weight-loss surgery died from any cause, compared with almost 1300 obese patients who didn’t have surgery, the learn found. Arterburn’s team estimated the death rates for the surgical patients was about 6 percent after five years and 13,8 percent at 10 years.

Parts: 1 2 3

Weight-Loss Surgery Can Prolong Life. Part 1 of 3

Tags

, ,

Weight-Loss Surgery Can Prolong Life – Part 1 of 3

Weight-Loss Surgery Can Prolong Life. Weight-loss surgery appears to drag out life for severely obese adults, a new study of US veterans finds. Among 2500 abdominous adults who underwent so-called bariatric surgery, the death rate was about 14 percent after 10 years compared with almost 24 percent for obese patients who didn’t have weight-loss surgery, researchers found. “Patients with inhuman obesity can have greater confidence that bariatric surgical procedures are associated with better long-term survival than not having surgery,” said lead researcher Dr David Arterburn, an allied investigator with the Group Health Research Institute in Seattle. Earlier studies have shown better survival among younger obese women who had weight-loss surgery, but this study confirms this verdict in older men and women who suffer from other health problems, such as diabetes and high blood pressure.

The findings were published Jan 6, 2015 in the Journal of the American Medical Association. “We were not able to adjudge in our study the reasons why veterans lived longer after surgery than they did without surgery. “However, other research suggests that bariatric surgery reduces the risk of diabetes, heart disease and cancer, which may be the water ways that surgery prolongs life”. Dr John Lipham, chief of upper gastrointestinal and general surgery at the Keck School of Medicine at the University of Southern California, Los Angeles, said that patients who have weight-loss surgery predominantly see their diabetes disappear

And “This by itself is going to provide a survival benefit. Shedding excess weight also lowers blood arm-twisting and cholesterol levels and reduces the odds of developing heart disease. “If you are obese and unable to lose weight on your own, bariatric surgery should be considered”. Arterburn said most insurance plans including Medicare charge bariatric surgery. As with any surgery, however, weight-loss surgery carries some risks.

Parts: 1 2 3

Use Of Cholesterol Drugs By Patients Without High Cholesterol Level. Part 3 of 3

Tags

, ,

Use Of Cholesterol Drugs By Patients Without High Cholesterol Level – Part 3 of 3

So Hlatky says he might still prescribe a statin for someone in that group, “but I would have an informed conversation about the long-term risks and benefits and what you emergency to do to reduce the risks. It is so much easier to prescribe a drug than to change behavior, and that is my worry. We’re heading down that road. Cardiovascular risk prevention is moving in the wrong direction”.

He’s also worried about exposing more woman in the street to the rare but still possible side effects that come with statins. The drugs can cause myalgia – severe muscle pain – and a recent study published in the British journal The Lancet found a 9 percent lengthen in diabetes incidence among people taking statins.

But Nissen believes the benefits of expanded use of Crestor outweigh possible risks. The study that found an increased extent of diabetes did not find that it was accompanied by any increase in cardiovascular problems and deaths nebraska. “The is one example where the FDA got it exactly right”.

Parts: 1 2 3

Use Of Cholesterol Drugs By Patients Without High Cholesterol Level. Part 2 of 3

Tags

, ,

Use Of Cholesterol Drugs By Patients Without High Cholesterol Level – Part 2 of 3

For that specific group, Crestor makes sense. “Over a five-year period of time, you nip in the bud one death or minor stroke for every 25 people treated”. Whether or not others with normal cholesterol should take Crestor or another statin remains unclear. “Not everyone with normal cholesterol should be treated. You should give it to the crowd with a high enough risk”.

cardiovascular

And he added that the results applied only to Crestor. Other popular statins include Lipitor, Pravachol and Zocor, as well as some generic versions. Those statins might not manufacture the same benefits. “Statins differ from each other in terms of potency”. Crestor, which is available only in a more expensive brand-name form, is toward the top of the list in terms of potency while generic drugs such as simvastatin (Zocor) and pravastatin (Pravachol) have much less persuasive effects.

“For patients who need a lot of cholesterol reduction, I use the most powerful drug. If I can get a patient there with a generic drug, of course I use a generic drug”. But Hlatky has his doubts about the advisability of widening statins’ reach. He said he’s unwilling to have people at cardiovascular risk pop a pill rather than change the lifestyle factors that put them in trouble in the first place.

“My rate has always been that you start with the basics and do the simple things first before you go to drugs. Lots of people are not doing the sensible things. They’re not eating the right diet, they’re not exercising, they’re still smoking. Most of the multitude in the JUPITER trial were smack in the middle of that group”.

Parts: 1 2 3

Use Of Cholesterol Drugs By Patients Without High Cholesterol Level. Part 1 of 3

Tags

, ,

Use Of Cholesterol Drugs By Patients Without High Cholesterol Level – Part 1 of 3

Use Of Cholesterol Drugs By Patients Without High Cholesterol Level. When the US Food and Drug Administration in February 2010 approved the use of the cholesterol-lowering statin tranquillizer Crestor for some nation with normal cholesterol levels, cardiologist Dr Steven E Nissen cheered the decision. “You have to go with the scientific evidence,” said Nissen, who is chairman of cardiovascular cure-all at the Cleveland Clinic. “A clinical trial was done and there was a substantial reduction in morbidity and mortality in people treated with this drug”.

But Dr Mark A Hlatky, a professor of trim research and policy and medicine at Stanford University, has expressed doubts about the FDA move. He worries that more people will rely on a pill rather than diet and exercise to cut their heart risk, and also points to studies linking statins such as Crestor to muscle troubles and even diabetes. “I haven’t seen anything that changes my thinking about that”.

So, will millions of healthy Americans soon join the millions of less-than-healthy commonalty who already take these blockbuster drugs? The FDA’s Feb 9 approval of expanded use of rosuvastatin (Crestor) was based on results of the JUPITER study, which involved more than 18000 people and was financed by the drug’s maker, AstraZeneca. People in the headache who took the drug for an average of 1,9 years had a 44 percent lower risk of heart attack, stroke and other cardiovascular problems compared to those who took a placebo – results so superior that the trial was cut short. Based on JUPITER, an FDA advisory committee voted 12 to 4 in December to approve widened use of the drug.

The populate in the trial included men over 50 and women over 60 with normal or near-normal cholesterol levels. However, these individuals did have high levels of C-reactive protein, a marker of inflammation that has also been linked to cardiovascular problems. They also had at least one other determination risk factor, such as obesity or high blood pressure.

Parts: 1 2 3

Significant Weight Gain During Pregnancy Increases The Risk Of Gestational Diabetes. Part 3 of 3

Tags

, ,

Significant Weight Gain During Pregnancy Increases The Risk Of Gestational Diabetes – Part 3 of 3

Glucose is your body’s main source of energy. After digestion, the glucose moves into your blood to give your body energy. To get the glucose out of your blood and into the cells of your body, your pancreas makes a hormone called insulin. If you have diabetes, either your body doesn’t construct enough insulin, or your cells can’t use it the way they should. Instead, the glucose builds up in your blood, causing diabetes, or costly blood sugar extenderdlx.com.

Parts: 1 2 3

Significant Weight Gain During Pregnancy Increases The Risk Of Gestational Diabetes. Part 2 of 3

Tags

, ,

Significant Weight Gain During Pregnancy Increases The Risk Of Gestational Diabetes – Part 2 of 3

Our research shows that weight gain in early pregnancy is a modifiable risk factor for gestational diabetes,” lead author Monique Hedderson, a scientist at the Kaiser Permanente Division of Research in California, said in a Kaiser scuttlebutt release. Gestational diabetes – which causes complications in as many as 7 percent of pregnancies in the United States – can lead to early delivery, cesarean cleave and type 2 diabetes in the mother.

diabetes

It also increases the child’s risk of developing diabetes and obesity later in life. Gestational diabetes, also known as gestational diabetes mellitus, GDM, or diabetes during pregnancy, is a species of diabetes that only pregnant women get.

If a woman gets diabetes when she is pregnant, but never had it before, then she has gestational diabetes. Normally, your stomach and intestines digest the carbohydrate in your bread into a sugar called glucose.

Parts: 1 2 3

Significant Weight Gain During Pregnancy Increases The Risk Of Gestational Diabetes. Part 1 of 3

Tags

, ,

Significant Weight Gain During Pregnancy Increases The Risk Of Gestational Diabetes – Part 1 of 3

Significant Weight Gain During Pregnancy Increases The Risk Of Gestational Diabetes. Excessive power gain during pregnancy, especially the first trimester, may increase a woman’s peril of gestational diabetes, say US researchers. Their three-year study included 345 pregnant women with gestational diabetes and 800 pregnant women without gestational diabetes, which is defined as glucose discrimination that typically occurs during the second or third trimester of pregnancy.

After the researchers adjusted for a number of factors – age at delivery, previous births, pre-pregnancy body-mass table of contents and race and/or ethnicity – they found that women who gained more weight during pregnancy than recommended by the US Institute of Medicine were 50 percent more likely to develop gestational diabetes, compared to those whose importance gain was within or below the IOM recommendations. The link between pregnancy weight gain and gestational diabetes was strongest among overweight and non-white women.

The study was published online Feb 22 in the minutes Obstetrics and Gynecology. “Health-care providers should talk to their patients early in their pregnancy about the appropriate gestational weight gain, especially during the first trimester, and help women monitor their ballast gain.

Parts: 1 2 3

The Medicaid Payment Provision Under Obamacare. Part 3 of 3

Tags

, ,

The Medicaid Payment Provision Under Obamacare – Part 3 of 3

Researchers thought the reimbursement increase would have a lesser effect on appointment availability in states that expanded Medicaid since there would be more indefatigable demand, but that was not the case. Both New Jersey, which expanded Medicaid, and Pennsylvania, which did not, had similar increases in seeing new patients, according to the study. The valetudinarian advocacy group Families USA released a document this week outlining proposed next steps for health reform, including a permanent adjustment to Medicaid rates to create parallelism with Medicare rates.

Primary-care physician groups are also pushing for restoration of the pay parity provision. “This is really among our top priority issues,” said Shari Erickson, vice president for governmental affairs and medical tradition at the American College of Physicians in Washington, DC, which represents internal medicine physicians genotropin. “I think that it’s unfortunate, obviously, to let a program expire that is showing promising data – both anecdotally and in this initial study here – before we can really assess its true effectiveness”.

Parts: 1 2 3